The consensus price target hints at a 148.9% upside potential for Knightscope (KSCP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...
The consensus price target hints at an 81.3% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward ...